Robert Berg, Senior Vice President, IRI
Katherine Bowdish, Ph.D., Vice President R&D and Head of Sunrise, Sanofi
Kapil Dhingra, MBBS, Managing Member, KAPital Consulting
Nick Donofrio, IBM Executive Vice President Innovation and Technology (Retired)
Terry J. Fetterhoff, Sr. Director, Head, US Chief Technology Office Diagnostics Division, Hoffmann-La Roche, Inc.
Mary Haak-Frendscho, Ph.D. Chief Executive Officer, Ingenica, Inc.
Eric Hale, J.D. M.S., MBA, Associate Director, Office of Clinical and Preclinical Development Partnerships, Center for Cancer Research, NCI
John D. Hewes, Ph. D. Technology Transfer Specialist, Technology Transfer Center, NCI
Marc Hurlbert, Ph.D. Executive Director, Avon Foundation Breast Cancer Crusade
Michael King Jolly, Pharm.D. Senior Vice President, Quintiles Innovation
Richard Lipkin, Venture Partner at Easton Capital Investment Group
James R. McCullough, Chief Executive Officer, Exosome Diagnostics
Carol Nacy, Founder and Chief Executive Officer, Sequella, Inc.
Christine K. Norton, Co-Founder, Minnesota Breast Cancer Coalition
Gil Price, M.D., Chief Executive Officer, Drug Safety Solutions
Thomas M. Stackhouse, Ph.D. Associate Director, Technology Transfer Center, NCI
George F. Tidmarsh, M.D., Ph.D. President, Chief Executive Officer, La Jolla Pharmaceutical Co.
Rosemarie Truman Founder and Chief Executive Officer, The Center for Advancing Innovation, INC.
"In addition to making an impact on breast cancer health, I believe this Challenge will fundamentally change the commercialization of NIH innovation and the business model of healthcare philanthropic funding," said George Tidmarsh, M.D., Ph.D. President, Chief Executive Officer and Secretary, La Jolla Pharmaceutical Co.
"Having worked with several organizations that launched monumental efforts, it's been exciting to see this Herculean startup challenge successfully catalyzed! I look forward to the outcomes that this Challenge will create," said Nick Donofrio, a retired IBM Executive Vice President of Innovation and Technology.
"The Business Plan and Start-up Challenge will create a new paradigm to link venture philanthropy and translational research to ignite economic growth and advance public health," said Rosemarie Truman, founder and CEO of The Center for Advancing Innovation. "The Avon Foundation for Women, the Technology Transfer Center of the NCI and The Center for Advancing Innovation are pioneering novel innovative models to create start-ups for promising inventions arising out of breast cancer research."
Source: The Center for Advancing Innovation (CAI)